Trademark: 88347483
Word
THE RNA PRINTER
Status
Registered
Status Code
700
Status Date
Tuesday, March 2, 2021
Serial Number
88347483
Registration Number
6285035
Registration Date
Tuesday, March 2, 2021
Mark Type
4000
Filing Date
Tuesday, March 19, 2019

Trademark Owner History
CUREVAC RNA PRINTER GMBH -
CureVac AG - Original Registrant

Classifications
5 Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements, namely, dietary food supplements
1 Chemical reagents and biomolecules, in particular biological macromolecules in the nature of nucleic acid for industrial or scientific purposes; Reagents for research purposes
44 Medical and veterinary services, in particular for therapeutic and preventative treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders
42 Scientific and technological services, namely, technical biology consulting and scientific research services, in particular for identifying and characterizing biological macromolecules; pre-clinical and clinical testing of macromolecules
"RNA"

Trademark Events
May 25, 2022
Automatic Update Of Assignment Of Ownership
Mar 2, 2021
Registered-Supplemental Register
Jan 28, 2021
Law Office Publication Review Completed
Jan 23, 2021
Approved For Registration Supplemental Register
Dec 30, 2020
Teas/Email Correspondence Entered
Dec 29, 2020
Correspondence Received In Law Office
Dec 29, 2020
Teas Request For Reconsideration Received
Jul 10, 2020
Notification Of Final Refusal Emailed
Jul 10, 2020
Final Refusal E-Mailed
Jul 10, 2020
Final Refusal Written
Jun 4, 2020
Teas/Email Correspondence Entered
Jun 4, 2020
Correspondence Received In Law Office
Jun 4, 2020
Teas Response To Office Action Received
Dec 5, 2019
Notification Of Non-Final Action E-Mailed
Dec 5, 2019
Non-Final Action E-Mailed
Dec 5, 2019
Non-Final Action Written
Nov 13, 2019
Teas/Email Correspondence Entered
Nov 5, 2019
Correspondence Received In Law Office
Nov 5, 2019
Teas Response To Suspension Inquiry Received
Nov 4, 2019
Notification Of Letter Of Suspension E-Mailed
Nov 4, 2019
Letter Of Suspension E-Mailed
Nov 4, 2019
Suspension Letter Written
Oct 15, 2019
Teas/Email Correspondence Entered
Oct 15, 2019
Correspondence Received In Law Office
Oct 10, 2019
Assigned To Lie
Oct 7, 2019
Teas Response To Office Action Received
Jun 5, 2019
Notification Of Non-Final Action E-Mailed
Jun 5, 2019
Non-Final Action E-Mailed
Jun 5, 2019
Non-Final Action Written
May 29, 2019
Assigned To Examiner
Apr 7, 2019
New Application Office Supplied Data Entered In Tram
Mar 22, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24